Revolutionary Step in B2B: The First Verified & Trusted Pharma, Surgical & Medical Trade Automation Platform • Direct Factory Deals, Global Tenders & 7-Document Export Dossiers•Revolutionary Step in B2B: The First Verified & Trusted Pharma, Surgical & Medical Trade Automation Platform • Direct Factory Deals, Global Tenders & 7-Document Export Dossiers•
Product Recalls & Safety Alerts

Regulatory Recall Advisory: Sub-Visible Particulate Matter & Glass Delamination in Parenteral Vials (USP <788>)

Safety alert issued to hospital pharmacies and parenteral importers regarding voluntary batch recalls triggered by visible particulate matter and inner-surface glass delamination in sterile intravenous solutions (HS Code 3004.90).

  • Compendial Standard: Small-volume parenterals (≤100 mL) must strictly meet USP <788> light obscuration limits (≤6,000 particles ≥10 μm and ≤600 particles ≥25 μm per container).
  • Importer Action: Distributors must verify Type I borosilicate glass hydrolytic resistance certifications (USP <660>) and inspect lot-release 100% automated optical inspection records prior to hospital distribution.

Official Source & Verification Reference

Issuing Authority: U.S. Food and Drug Administration (FDA) • Reference: FDA-ENF-RECALL-2026-08

Verify Official Source Document ↗